Connection

RICHARD BOND to Animals

This is a "connection" page, showing publications RICHARD BOND has written about Animals.
Connection Strength

0.497
  1. ?2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility. Proc Natl Acad Sci U S A. 2017 10 24; 114(43):E9163-E9171.
    View in: PubMed
    Score: 0.033
  2. Effects of ?-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype. Pulm Pharmacol Ther. 2017 Oct; 46:30-40.
    View in: PubMed
    Score: 0.032
  3. Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by ?2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice. Am J Respir Cell Mol Biol. 2016 08; 55(2):234-42.
    View in: PubMed
    Score: 0.030
  4. Differences in asthma study models and the effectiveness of ?2 -adrenoceptor ligands: response to Lipworth et al. Br J Pharmacol. 2016 Jan; 173(1):250-1.
    View in: PubMed
    Score: 0.029
  5. Dynamic bias and its implications for GPCR drug discovery. Nat Rev Drug Discov. 2014 Nov; 13(11):869.
    View in: PubMed
    Score: 0.027
  6. Complementary anti-inflammatory effects of a ?-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb; 385(2):203-10.
    View in: PubMed
    Score: 0.021
  7. New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28.
    View in: PubMed
    Score: 0.021
  8. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9.
    View in: PubMed
    Score: 0.020
  9. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40.
    View in: PubMed
    Score: 0.018
  10. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol. 2008 Mar; 38(3):256-62.
    View in: PubMed
    Score: 0.017
  11. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther. 2008; 21(1):115-24.
    View in: PubMed
    Score: 0.016
  12. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci. 2006 Feb; 27(2):92-6.
    View in: PubMed
    Score: 0.014
  13. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A. 2004 Apr 06; 101(14):4948-53.
    View in: PubMed
    Score: 0.013
  14. Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery. Br J Pharmacol. 2003 Apr; 138(8):1505-16.
    View in: PubMed
    Score: 0.012
  15. Can intellectualism stifle scientific discovery? Nat Rev Drug Discov. 2002 Oct; 1(10):825-9.
    View in: PubMed
    Score: 0.012
  16. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor. J Cardiovasc Pharmacol. 2002 Sep; 40(3):448-55.
    View in: PubMed
    Score: 0.011
  17. Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats. Neurosci Lett. 2020 04 23; 725:134892.
    View in: PubMed
    Score: 0.010
  18. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Br J Pharmacol. 1999 Jul; 127(5):1099-104.
    View in: PubMed
    Score: 0.009
  19. Adrenoceptors-New roles for old players. Br J Pharmacol. 2019 07; 176(14):2339-2342.
    View in: PubMed
    Score: 0.009
  20. Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci. 1997 Dec; 18(12):468-74.
    View in: PubMed
    Score: 0.008
  21. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice. Mol Pharmacol. 1997 Aug; 52(2):187-94.
    View in: PubMed
    Score: 0.008
  22. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212.
    View in: PubMed
    Score: 0.007
  23. ?-Blockers have differential effects on the murine asthma phenotype. Br J Pharmacol. 2015 Oct; 172(20):4833-46.
    View in: PubMed
    Score: 0.007
  24. Epinephrine Activation of the ?2-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells. PLoS One. 2015; 10(7):e0132559.
    View in: PubMed
    Score: 0.007
  25. Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol. 2015 Jul; 172(14):3461-71.
    View in: PubMed
    Score: 0.007
  26. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature. 1995 Mar 16; 374(6519):272-6.
    View in: PubMed
    Score: 0.007
  27. Ligand bias prevents class equality among beta-blockers. Curr Opin Pharmacol. 2014 Jun; 16:50-7.
    View in: PubMed
    Score: 0.006
  28. GPCRs and arrestins in airways: implications for asthma. Handb Exp Pharmacol. 2014; 219:387-403.
    View in: PubMed
    Score: 0.006
  29. Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2013 Sep; 49(3):502.
    View in: PubMed
    Score: 0.006
  30. Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory. Neurosci Lett. 2013 Aug 26; 548:296-300.
    View in: PubMed
    Score: 0.006
  31. Interaction of tertatolol at the "atypical" or beta 3-adrenoceptor in guinea-pig ileum. Gen Pharmacol. 1992 Mar; 23(2):171-6.
    View in: PubMed
    Score: 0.006
  32. Partial agonistic activity of GR43175 at the inhibitory prejunctional 5-HT1-like receptor in rat kidney. J Auton Pharmacol. 1989 Jun; 9(3):201-10.
    View in: PubMed
    Score: 0.005
  33. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation. J Pharmacol Exp Ther. 1989 May; 249(2):401-10.
    View in: PubMed
    Score: 0.005
  34. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol. 1988 Nov; 95(3):723-34.
    View in: PubMed
    Score: 0.004
  35. A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism. Br J Pharmacol. 1987 Jul; 91(3):683-6.
    View in: PubMed
    Score: 0.004
  36. Evidence for a receptor mediated action of norepinephrine distinct from alpha- and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov; 334(3):261-6.
    View in: PubMed
    Score: 0.004
  37. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. J Pharmacol Exp Ther. 1986 Feb; 236(2):408-15.
    View in: PubMed
    Score: 0.004
  38. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 2004 Jul; 25(7):358-65.
    View in: PubMed
    Score: 0.003
  39. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation. 2003 Sep 30; 108(13):1633-9.
    View in: PubMed
    Score: 0.003
  40. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2003 Aug 05; 108(5):598-604.
    View in: PubMed
    Score: 0.003
  41. Frequency dependence of respiratory system mechanics during induced constriction in a murine model of asthma. J Appl Physiol (1985). 2003 Jan; 94(1):245-52.
    View in: PubMed
    Score: 0.003
  42. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. J Leukoc Biol. 2001 Apr; 69(4):631-8.
    View in: PubMed
    Score: 0.003
  43. Altered baroreflex responses in alpha7 deficient mice. Behav Brain Res. 2000 Aug; 113(1-2):3-10.
    View in: PubMed
    Score: 0.002
  44. Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci U S A. 1997 Jan 07; 94(1):137-41.
    View in: PubMed
    Score: 0.002
  45. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12974-9.
    View in: PubMed
    Score: 0.002
  46. Potentiation of endothelium-dependent hyperpolarization to serotonin by dietary intake of NC 020, a defined fish oil, in the porcine coronary artery. J Cardiovasc Pharmacol. 1995 Nov; 26(5):679-81.
    View in: PubMed
    Score: 0.002
  47. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995 Jun 02; 268(5215):1350-3.
    View in: PubMed
    Score: 0.002
  48. Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):236-41.
    View in: PubMed
    Score: 0.002
  49. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci. 1995 Jan; 16(1):10-3.
    View in: PubMed
    Score: 0.002
  50. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):10109-13.
    View in: PubMed
    Score: 0.002
  51. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science. 1994 Apr 22; 264(5158):582-6.
    View in: PubMed
    Score: 0.002
  52. Effects of S9977 on adrenergic neurotransmission. Gen Pharmacol. 1993 Mar; 24(2):429-34.
    View in: PubMed
    Score: 0.001
  53. The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. J Cardiovasc Pharmacol. 1993; 22 Suppl 7:S10-6.
    View in: PubMed
    Score: 0.001
  54. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991 Jun; 17(6):964-9.
    View in: PubMed
    Score: 0.001
  55. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol. J Pharmacol Exp Ther. 1990 Mar; 252(3):1034-42.
    View in: PubMed
    Score: 0.001
  56. An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan; 332(1):8-15.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.